GRIFOLS | GRF - Operating Profit

Stock Price
8.95
Daily Change
0 0%
Monthly
-0.11%
Yearly
5.12%
Q2 Forecast
8.72

GRIFOLS reported EUR275.38M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Alcon AG USD 313M 19M Dec/2025
Almirall EUR 30.23M 12.8M Dec/2025
Amadeus IT EUR 338.9M 142.6M Dec/2025
Amarin USD -2.26M 564K Dec/2025
argenx SE USD 371.14M 21.17M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Bayer EUR 1.11B 1.65B Dec/2025
Cie Automotive EUR 264.84M 21.12M Dec/2025
Demant DKK 2.09B 224M Dec/2025
Ence Energia y Celulosa EUR -37.27M 22.77M Dec/2025
Essilor EUR 1.38B 626M Dec/2025
Ferrovial EUR 1000K 430M Dec/2025
Fresenius EUR 713M 139M Dec/2025
Fresenius Medical Care EUR 663M 213.06M Dec/2025
Galapagos EUR 780.56M 822.23M Dec/2025
Genmab DKK 260M 199M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 275.38M 76.74M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Inditex EUR 2.05B 317M Dec/2025
Merck EUR 474M 738M Dec/2025
Novartis USD 4.06B 437M Dec/2025
Philips EUR 719M 390M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.94B 239M Mar/2026
Smith & Nephew USD 440M 50M Dec/2025
UCB EUR 1.29B 571M Dec/2025
Viscofan EUR 42.17M 8.14M Mar/2026